Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001171843-18-002302
Filing Date
2018-03-27
Accepted
2018-03-27 11:50:13
Documents
3
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A f10ka_032718.htm 10-K/A 759228
2 EXHIBIT 31.1 exh_311.htm EX-31.1 2380
3 EXHIBIT 31.2 exh_312.htm EX-31.2 2528
  Complete submission text file 0001171843-18-002302.txt   765184
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-23186 | Film No.: 18714559
SIC: 2836 Biological Products, (No Diagnostic Substances)